At least 70 people are
believed to have died in the Pakistani city of Lahore over the past
three weeks because of faulty heart drugs, officials say.
They said that at least 400 others are being treated for similar symptoms.
The number of dead has soared since Tuesday, when officials
said about 36 people with cardiovascular problems had died since the
start of the month.
The owners of three local drugs companies alleged to have supplied the contaminated drugs have been arrested.
The deaths have caused panic in the city less than three months after a dengue fever epidemic.
Officials have warned that the batch of contaminated drugs
might have been distributed to nearly 40,000 people since 15 December.
They say that patients affected by the sub-standard drugs suffer a rapid
depletion of white cells and blood platelets.
The symptoms - first noticed in late December - created an
impression that patients were suffering a form of dengue fever, a
mosquito-borne disease common in Pakistan during the monsoon season,
officials say.
But patient data soon revealed that all of those affected
were heart patients who had been using free cardiovascular drugs from
the government-run Punjab Institute of Cardiology.
Publicity campaign
Officials told the BBC that the deaths appear to have been caused by a batch of drugs issued on 15 December.
They say one or more of at least six drugs - all manufactured
by little-known local firms and purchased by the Institute of
Cardiology for heart patients - may be responsible.
The parliamentary health secretary for Punjab, Saeed Illahi,
told the BBC that about 400 heart patients were ill from taking the
drugs. About 100 had been admitted to hospital, with many of them still
in a critical condition.
Drug samples have been sent to London and Paris for further investigation, he said.
Officials of the Federal Investigation Agency (FIA) told a
court in Lahore on Wednesday that the drugs did not carry dates of
manufacture and expiry.
The court has remanded in custody three people who own
pharmaceutical firms which supplied the drugs to the Institute of
Cardiology. The owners of two other companies are being sought, Mr
Illahi said.
None of the firms has commented on the allegations.
The institute provides free heart drugs to about 600,000 heart patients annually.
Hospital sources have told the BBC that if they do not buy
medicines from the cheapest supplier they can be taken to court by drug
companies.
The government has now launched a publicity campaign warning people not to use the faulty batch of drugs.
The BBC's M Ilyas Khan in Islamabad says the Pakistani
pharmaceuticals market is intensely competitive, with local companies
competing with multinationals for hospital contracts.
No comments:
Post a Comment